PUBLISHER: The Business Research Company | PRODUCT CODE: 1946959
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946959
Phacoemulsification systems are advanced medical devices that use ultrasonic energy to break up and remove the eye's natural lens during cataract surgery, enabling the placement of an artificial intraocular lens (IOL) to restore clear vision. They are engineered to deliver precise control over fluidics, pressure, and energy output, ensuring safety, efficiency, and optimal surgical performance.
The primary product types of phacoemulsification systems include standalone phacoemulsification systems and portable phacoemulsification systems. Standalone phacoemulsification systems are fully integrated, stationary surgical units designed specifically for carrying out phacoemulsification procedures in ophthalmology. These systems employ various technologies-such as ultrasound, femtosecond laser, and others-to support a wide range of ophthalmic treatments. Key disease indications include cataract, presbyopia, glaucoma, and additional conditions. The primary applications for these systems are cataract surgery, refractive surgery, and other related procedures. They are utilized across multiple end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare facilities.
Tariffs are impacting the phacoemulsification system market by increasing costs of ultrasonic components, precision electronics, and surgical consoles sourced globally. North America and Europe are most affected due to reliance on Asia-Pacific manufacturing hubs. These tariffs have slightly increased equipment prices and delayed procurement cycles. However, they are encouraging localized manufacturing, supplier diversification, and innovation in cost-efficient surgical platforms.
The phacoemulsification system market research report is one of a series of new reports from The Business Research Company that provides phacoemulsification system market statistics, including phacoemulsification system industry global market size, regional shares, competitors with a phacoemulsification system market share, detailed phacoemulsification system market segments, market trends and opportunities, and any further data you may need to thrive in the phacoemulsification system industry. This phacoemulsification system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The phacoemulsification system market size has grown strongly in recent years. It will grow from $1.51 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising cataract prevalence, aging population growth, adoption of phaco techniques, ophthalmic infrastructure expansion, surgeon preference for minimally invasive tools.
The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in outpatient eye surgeries, technological innovation in ultrasound systems, rising demand for premium IOLs, expansion in emerging markets, increasing vision care awareness. Major trends in the forecast period include advanced fluidics control systems, minimally invasive cataract surgery adoption, high precision ultrasonic energy delivery, faster surgical procedure times, improved patient safety outcomes.
The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification systems support minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Gov.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, the increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system market.
Key companies operating in the phacoemulsification system market are focusing on integrating femtosecond laser technology, such as advanced fluidics concepts that maintain stable intraocular pressure (IOP), enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Advanced fluidics concepts refer to fluid management technologies in phacoemulsification systems that precisely regulate the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, introduced Virtuoso, a dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system includes an innovative fluidics concept that maintains target intraocular pressure (IOP) during all surgical steps, a hybrid flow and pressure pump design for improved chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to improve precision and surgical efficiency.
In January 2024, Rayner Group, a UK-based ophthalmic technology company, acquired This AG for an undisclosed amount. Through this acquisition, Rayner aims to strengthen its cataract-surgery portfolio by integrating advanced phaco-emulsification capabilities and expanding its presence in global surgical ophthalmology. This AG is a Switzerland-based ophthalmic technology company that develops phacoemulsification systems.
Major companies operating in the phacoemulsification system market are Alcon, Johnson & Johnson, Bausch + Lomb, NIDEK, Oertli Instrumente, Optikon, Geuder, Appasamy Associates, Biotech Visioncare, Meda, SIFI, Ziemer Ophthalmic Systems, Topcon, Carl Zeiss Meditec, Huvitz, Rumex International, DORC International, MicroSurgical Technology, LIGHTMED, Aurolab, MTP Medical Technical Products
North America was the largest region in the phacoemulsification system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phacoemulsification system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the phacoemulsification system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The phacoemulsification systems market consists of sales of surgical equipment, consoles, handpieces, tubing sets, cassettes, and irrigation or aspiration components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Phacoemulsification System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses phacoemulsification system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for phacoemulsification system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phacoemulsification system market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.